# Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

> **NCT05897086** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Vanderbilt University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Gender Dysphoria

## Interventions

- **DRUG:** Polyethylene Glycol 3350

## Key facts

- **NCT ID:** NCT05897086
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-08-01
- **Primary completion:** 2028-12-30
- **Final completion:** 2029-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05897086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05897086, "Polyethylene-glycol Assisted Nerve Repair in Phalloplasty". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05897086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*